Harlan S. Robins, Chief Scientific Officer at Adaptive Biotechnologies Corp (ADPT), sold 1,698 shares at $9.00 ($15K) on 2025-03-24, disclosed to the SEC on 2025-03-26.
Scheduled sale ($15k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ADPT | SELL | 2026-06-17 | $1.8M | — | Filing → |
| ADPT | SELL | 2026-04-10 | $149K | — | Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |